Position in SUPN
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$1,385,997
-$1,104,427 QoQ
Shares Held
29,800
-38.1% QoQ
Ownership
0.051%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#119
of 331 holders
Holding Since
Sep 2021
8 quarters on record
Voting authority
Sole 81%
Shared 0%
None 19%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026GREAT LAKES ADVISORS, LLC holds $28,941,933 across 12 Drug Manufacturers - Specialty & Generic names. SUPN ranks #7 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
245,707 | $6,046,849 | |
| 2 | ANIP |
Ani Pharmaceuticals Inc
|
61,481 | $5,089,396 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
36,680 | $4,069,278 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
7,399 | $4,008,999 | |
| 5 | PBH |
Prestige Consumer Healthcare Inc.
|
63,058 | $2,980,750 | |
| 6 | VTRS |
Viatris Inc
|
158,650 | $2,519,362 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
This page
|
29,800 | $1,385,997 | |
| 8 | HROW |
Harrow, Inc.
|
26,963 | $1,145,118 |
All Filings in SUPN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,385,997 | 29,800 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $2,490,424 | 48,180 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $2,614,915 | 52,614 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $3,404,128 | 71,231 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $4,481,545 | 142,181 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $5,357,245 | 163,580 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $6,131,181 | 169,557 | Shares | Sole | 2025-02-10 | |
| 2021-09-30 | $216,080 | 8,102 | Shares | Sole | 2021-11-09 | |
| No filing history on record for this holder in this stock. | ||||||